| Quantitative measurement and control of oxygen levels in microfluidic poly (dimethylsiloxane) bioreactors during cell culture G Mehta, K Mehta, D Sud, JW Song, T Bersano-Begey, N Futai, YS Heo, ... Biomedical microdevices 9, 123-134, 2007 | 267 | 2007 |
| Optical imaging in microfluidic bioreactors enables oxygen monitoring for continuous cell culture D Sud, G Mehta, K Mehta, J Linderman, S Takayama, MA Mycek Journal of biomedical optics 11 (5), 050504-050504-3, 2006 | 121 | 2006 |
| Translational pharmacokinetic/pharmacodynamic modeling of tumor growth inhibition supports dose‐range selection of the anti–PD‐1 antibody pembrolizumab A Lindauer, CR Valiathan, K Mehta, V Sriram, R De Greef, ... CPT: pharmacometrics & systems pharmacology 6 (1), 11-20, 2017 | 119 | 2017 |
| Model‐based analysis and design of a microchannel reactor for tissue engineering K Mehta, JJ Linderman Biotechnology and bioengineering 94 (3), 596-609, 2006 | 57 | 2006 |
| Phase-locked signals elucidate circuit architecture of an oscillatory pathway A Jovic, B Howell, M Cote, SM Wade, K Mehta, A Miyawaki, RR Neubig, ... PLoS computational biology 6 (12), e1001040, 2010 | 53 | 2010 |
| Preclinical experimental and mathematical approaches for assessing effective doses of inhaled drugs, using mometasone to support human dose predictions M Caniga, A Cabal, K Mehta, DS Ross, MA Gil, JD Woodhouse, J Eckman, ... Journal of aerosol medicine and pulmonary drug delivery 29 (4), 362-377, 2016 | 22 | 2016 |
| Dynamics of molecular weight distributions for polymer scission K Mehta, G Madras AIChE journal 47 (11), 2539-2547, 2001 | 22 | 2001 |
| A computational approach to inferring cellular protein‐binding affinities from quantitative fluorescence resonance energy transfer imaging K Mehta, AD Hoppe, R Kainkaryam, PJ Woolf, JJ Linderman Proteomics 9 (23), 5371-5383, 2009 | 20 | 2009 |
| Quantitative inference of cellular parameters from microfluidic cell culture systems K Mehta, G Mehta, S Takayama, J Linderman Biotechnology and bioengineering 103 (5), 966-974, 2009 | 20 | 2009 |
| Mathematical model of bone remodeling captures the antiresorptive and anabolic actions of various therapies DS Ross, K Mehta, A Cabal Bulletin of mathematical biology 79, 117-142, 2017 | 17 | 2017 |
| A semimechanistic model of the time‐course of release of PTH into plasma following administration of the calcilytic JTT‐305/MK‐5442 in humans A Cabal, K Mehta, DS Ross, RP Shrestha, W Comisar, A Denker, SM Pai, ... Journal of Bone and Mineral Research 28 (8), 1830-1836, 2013 | 14 | 2013 |
| Development and validation for simultaneous estimation of famotidine and diclofenac poatassium in combined tablet dosage form by first order derivative method K Mehta, BS Kumar, A Dubey International Journal of Research in Pharmacy and Chemistry 2 (4), 1023-1028, 2012 | 13 | 2012 |
| In-silico lung modeling platform for inhaled drug delivery A Cabal, G Jajamovich, K Mehta, P Guo, A Przekwas Proceedings Drug Delivery to the Lungs 27, 82-86, 2016 | 11 | 2016 |
| DYNAMICS OF BONE CELL SIGNALING AND PTH TREATMENTS OF OSTEOPOROSIS. DS Ross, C Battista, A Cabal, K Mehta Discrete & Continuous Dynamical Systems-Series B 17 (6), 2012 | 6 | 2012 |
| Computational Analysis of Cytokine Release Following Bispecific T-Cell Engager Therapy: Applications of a Logic-Based Model G Selvaggio, S Parolo, P Bora, L Leonardelli, J Harrold, L Marchetti Frontiers in Oncology 12, 818641, 2022 | 5 | 2022 |
| Characterizing pharmacokinetic–pharmacodynamic relationships and efficacy of PI3Kδ inhibitors in respiratory models of TH2 and TH1 inflammation RL McLeod, MA Gil, D Chen, A Cabal, J Katz, J Methot, JD Woodhouse, ... Journal of Pharmacology and Experimental Therapeutics 369 (2), 223-233, 2019 | 4 | 2019 |
| Characterization of clinical pharmacokinetics and exposure-response relationships of AMG 330, a bispecific CD33 T-cell engager antibody construct, in patients with relapsed … SK Agarwal, S Bhagwat, K Mehta, A Hindoyan, AS Stein, F Ravandi, ... Journal of Clinical Oncology 38 (15_suppl), 7536-7536, 2020 | 2 | 2020 |
| Mechanistic pharmacokinetic/pharmacodynamic modeling in support of a patient-convenient, longer dosing interval for carfilzomib, a covalent inhibitor of the proteasome MR Yago, K Mehta, M Bose, S Bhagwat, VS Chopra, S Dutta, VV Upreti Clinical Pharmacokinetics 62 (5), 779-788, 2023 | 1 | 2023 |
| ACCURATE PREDICTION OF CLINICAL PHARMACOKINETICS OF THREE GENERATIONS OF BISPECIFIC T-CELL ENGAGERS (CANONICAL BITE CONSTRUCT; HALF-LIFE EXTENDED BITE CONSTRUCT; BISPECIFIC … V Upreti, M Yago, J Kast, D Zhou, H Wong, S Dhuria, S Agarwal, ... CLINICAL PHARMACOLOGY & THERAPEUTICS 109, S56-S56, 2021 | 1 | 2021 |
| Systems and methods for estimating tumor growth A Pourzanjani, K Mehta, VV Upreti US Patent App. 18/371,318, 2024 | | 2024 |
